🇺🇸 FDA
Patent

US 8383654

Heterocyclic antagonists of prostaglandin D2 receptors

granted A61KA61K31/4174A61K31/4178

Quick answer

US patent 8383654 (Heterocyclic antagonists of prostaglandin D2 receptors) held by Panmira Pharmaceuticals, LLC expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Panmira Pharmaceuticals, LLC
Grant date
Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4174, A61K31/4178, A61P, A61P1/00